GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FullHope Biomedical Co Ltd (ROCO:7773) » Definitions » EV-to-FCF

FullHope Biomedical Co (ROCO:7773) EV-to-FCF : (As of Apr. 06, 2025)


View and export this data going back to 2024. Start your Free Trial

What is FullHope Biomedical Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, FullHope Biomedical Co's Enterprise Value is NT$1,058.92 Mil. FullHope Biomedical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was NT$0.00 Mil. Therefore, FullHope Biomedical Co's EV-to-FCF for today is .

The historical rank and industry rank for FullHope Biomedical Co's EV-to-FCF or its related term are showing as below:

ROCO:7773' s EV-to-FCF Range Over the Past 10 Years
Min: -40.59   Med: -18.29   Max: -14.43
Current: -31.06

During the past 3 years, the highest EV-to-FCF of FullHope Biomedical Co was -14.43. The lowest was -40.59. And the median was -18.29.

ROCO:7773's EV-to-FCF is ranked worse than
100% of 460 companies
in the Biotechnology industry
Industry Median: 2.335 vs ROCO:7773: -31.06

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-06), FullHope Biomedical Co's stock price is NT$39.95. FullHope Biomedical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was NT$-1.460. Therefore, FullHope Biomedical Co's PE Ratio (TTM) for today is At Loss.


FullHope Biomedical Co EV-to-FCF Historical Data

The historical data trend for FullHope Biomedical Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FullHope Biomedical Co EV-to-FCF Chart

FullHope Biomedical Co Annual Data
Trend Dec21 Dec22 Dec23
EV-to-FCF
- - -

FullHope Biomedical Co Semi-Annual Data
Dec22 Jun23 Dec23 Jun24
EV-to-FCF - - - -

Competitive Comparison of FullHope Biomedical Co's EV-to-FCF

For the Biotechnology subindustry, FullHope Biomedical Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


FullHope Biomedical Co's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, FullHope Biomedical Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where FullHope Biomedical Co's EV-to-FCF falls into.


;
;

FullHope Biomedical Co EV-to-FCF Calculation

FullHope Biomedical Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1058.920/0
=

FullHope Biomedical Co's current Enterprise Value is NT$1,058.92 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. FullHope Biomedical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was NT$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


FullHope Biomedical Co  (ROCO:7773) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

FullHope Biomedical Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=39.95/-1.460
=At Loss

FullHope Biomedical Co's share price for today is NT$39.95.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. FullHope Biomedical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was NT$-1.460.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


FullHope Biomedical Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of FullHope Biomedical Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


FullHope Biomedical Co Business Description

Traded in Other Exchanges
N/A
Address
Lane 609, Sector. 5, Chongxin Road, 10th Floor, No. 10, Sanchong District, New Taipei City, TWN
FullHope Biomedical Co Ltd focuses on immune system-related services and innovative R&D. It establishes cell-based immunotherapies for cancers and autoimmune disorders. Its services are, Immunoprofiling, Circulating Tumor Cells Testing, Regulation of Cell Therapy, Contracting Immune Cell Manufacturing, Immune Cell Bank, Contract Research Organization, and Endotoxin and Mycoplasma Detection Service.

FullHope Biomedical Co Headlines

No Headlines